FCGBP and hepatocellular carcinoma: Whereas the clinicopathological subtypes (including T1, pathologic stage I, and non-vascular invasion) were not statistically correlated with OS of patients with HCC (P > 0.05) (Figure S1c–S1e), suggesting the negative correlations between FCGBP expression levels and prognosis of patients with HCC.